Prognostic Value of Quantitative Flow Ratio Combined with SYNTAX Scores I/II in Multivessel Coronary Artery Disease: A Small-Sample, Single-Center Study

被引:1
作者
Zhang, Shuyi [1 ]
Wang, Ming [1 ]
Gan, Qian [1 ]
Zhai, Xinrong [1 ]
Chen, Yang [1 ]
Guan, Shaofeng [1 ]
Xu, Xinxin [1 ]
Wen, Jiasheng [2 ]
Qu, Xinkai [1 ]
Han, Wenzheng [1 ]
机构
[1] Fudan Univ, Dept Cardiol, Huadong Hosp, Shanghai 200040, Peoples R China
[2] Kunshan Hosp Tradit Chinese Med, Dept Cardiol, Kunshan 215300, Jiangsu, Peoples R China
关键词
multivessel disease; SYNTAX score I; SYNTAX score II; quantitative flow ratio; functional SYNTAX score; CLINICAL-OUTCOMES; DECISION-MAKING; FOLLOW-UP; INTERVENTION; REVASCULARIZATION; SURGERY; ANGIOGRAPHY; VALIDATION; RESERVE; TRIAL;
D O I
10.31083/j.rcm2509329
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A fractional flow reserve (FFR)-fixed-SYNTAX score could decrease the number of high-risk patients. This study explored the prognostic value of non-invasive quantitative flow ratio (QFR)-fixed-SYNTAX I/II scores in multivessel disease patients.Methods: This was a single-center, small-sample, observational study. Multivessel coronary disease patients were enrolled and finished a 1-year follow-up. SYNTAX scores I/II and functional SYNTAX scores I/II based on QFR (cut-off value of 0.85) were calculated for all patients. The composite occurrence of cardiac deaths, any myocardial infarction, or ischemia-driven revascularization were analyzed using a different score system.Results: A total of 160 patients were stratified into risk groups based on a different scoring system. FSS (functional SYNTAX score) and FSSII (functional SYNTAX score II) reduce the radio of high-risk major adverse cardiovascular events (MACEs), transforming the patients from high-risk to medium- and low-risk. Furthermore, FSSII (hazard ratio (HR): 1.069, 95% CI: 1.025-1.115, p = 0.002) showed a better relationship with MACEs than the other score systems. After recalculating SSII, the survival-free ratio stratified by FSSII decreased from 38.46% to 27.27% in the high-risk group and increased from 84.09% to 86.05% in the low-risk group.Conclusions: FSS or FSSII could decrease the number of high-risk patients compared to SYNTAX score (SS) and FSS. SYNTAX II score (SSII) and FSSII showed a better predictive ability than other scoring systems for under-risk stratification.
引用
收藏
页数:9
相关论文
共 23 条
[1]   Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study [J].
Banning, Adrian P. ;
Serruys, Patrick ;
De Maria, Giovanni Luigi ;
Ryan, Nicola ;
Walsh, Simon ;
Gonzalo, Nieves ;
van Geuns, Robert Jan ;
Onuma, Yoshinobu ;
Sabate, Manel ;
Davies, Justin ;
Lesiak, Maciej ;
Moreno, Raul ;
Cruz-Gonzalez, Ignacio ;
Hoole, Stephen P. ;
Piek, Jan J. ;
Appleby, Clare ;
Fath-Ordoubadi, Farzin ;
Zaman, Azfar ;
Van Mieghem, Nicolas M. ;
Uren, Neal ;
Zueco, Javier ;
Buszman, Pawel ;
Iniguez, Andres ;
Goicolea, Javier ;
Hildick-Smith, David ;
Ochala, Andrzej ;
Dudek, Dariusz ;
de Vries, Ton ;
Taggart, David ;
Farooq, Vasim ;
Spitzer, Ernest ;
Tijssen, Jan ;
Escaned, Javier .
EUROPEAN HEART JOURNAL, 2022, 43 (13) :1307-1316
[2]   Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery Disease [J].
Choi, Ki Hong ;
Lee, Joo Myung ;
Koo, Bon-Kwon ;
Nam, Chang-Wook ;
Shin, Eun-Seok ;
Doh, Joon-Hyung ;
Rhee, Tae-Min ;
Hwang, Doyeon ;
Park, Jonghanne ;
Zhang, Jinlong ;
Kim, Kyung-Jin ;
Hu, Xinyang ;
Wang, Jianan ;
Ye, Fei ;
Chen, Shaoliang ;
Yang, Junqing ;
Chen, Jiyan ;
Tanaka, Nobuhiro ;
Yokoi, Hiroyoshi ;
Matsuo, Hitoshi ;
Takashima, Hiroaki ;
Shiono, Yasutsugu ;
Akasaka, Takashi .
JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (03) :237-245
[3]   Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study [J].
Escaned, Javier ;
Collet, Carlos ;
Ryan, Nicola ;
De Maria, Giovanni Luigi ;
Walsh, Simon ;
Sabate, Manel ;
Davies, Justin ;
Lesiak, Maciej ;
Moreno, Raul ;
Cruz-Gonzalez, Ignacio ;
Hoole, Stephan P. ;
West, Nick Ej ;
Piek, J. J. ;
Zaman, Azfar ;
Fath-Ordoubadi, Farzin ;
Stables, Rodney H. ;
Appleby, Clare ;
van Mieghem, Nicolas ;
van Geuns, Robert Jm. ;
Uren, Neal ;
Zueco, Javier ;
Buszman, Pawel ;
Iniguez, Andres ;
Goicolea, Javier ;
Hildick-Smith, David ;
Ochala, Andrzej ;
Dudek, Dariusz ;
Hanratty, Colm ;
Cavalcante, Rafael ;
Kappetein, Arie Pieter ;
Taggart, David P. ;
van Es, Gerrit-Anne ;
Morel, Marie-Angele ;
de Vries, Ton ;
Onuma, Yoshinobu ;
Farooq, Vasim ;
Serruys, Patrick W. ;
Banning, Adrian P. .
EUROPEAN HEART JOURNAL, 2017, 38 (42) :3124-3134
[4]   Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II [J].
Farooq, Vasim ;
van Klaveren, David ;
Steyerberg, Ewout W. ;
Meliga, Emanuele ;
Vergouwe, Yvonne ;
Chieffo, Alaide ;
Kappetein, Arie Pieter ;
Colombo, Antonio ;
Holmes, David R., Jr. ;
Mack, Michael ;
Feldman, Ted ;
Morice, Marie-Claude ;
Stahle, Elisabeth ;
Onuma, Yoshinobu ;
Morel, Marie-angele ;
Garcia-Garcia, Hector M. ;
van Es, Gerrit Anne ;
Dawkins, Keith D. ;
Mohr, Friedrich W. ;
Serruys, Patrick W. .
LANCET, 2013, 381 (9867) :639-650
[5]   Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) [J].
Fearon, William F. ;
Nishi, Takeshi ;
De Bruyne, Bernard ;
Boothroyd, Derek B. ;
Barbato, Emanuele ;
Tonino, Pim ;
Juni, Peter ;
Pijls, Nico H. J. ;
Hlatky, Mark A. .
CIRCULATION, 2018, 137 (05) :480-487
[6]   Association of quantitative flow ratio-derived microcirculatory indices with anatomical-functional discordance in intermediate coronary lesions [J].
Geng, Liang ;
Yuan, Yuan ;
Du, Peizhao ;
Gao, Liming ;
Wang, Yunkai ;
Li, Jiming ;
Guo, Wei ;
Huang, Ying ;
Zhang, Qi .
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2021, 37 (10) :2803-2813
[7]   Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data [J].
Head, Stuart J. ;
Milojevic, Milan ;
Daemen, Joost ;
Ahn, Jung-Min ;
Boersma, Eric ;
Christiansen, Evald H. ;
Domanski, Michael J. ;
Farkouh, Michael E. ;
Flather, Marcus ;
Fuster, Valentin ;
Hlatky, Mark A. ;
Holm, Niels R. ;
Hueb, Whady A. ;
Kamalesh, Masoor ;
Kim, Young-Hak ;
Makikallio, Timo ;
Mohr, Friedrich W. ;
Papageorgiou, Grigorios ;
Park, Seung-Jung ;
Rodriguez, Alfredo E. ;
Sabik, Joseph F., III ;
Stables, Rodney H. ;
Stone, Gregg W. ;
Serruys, Patrick W. ;
Kappetein, Arie Pieter .
LANCET, 2018, 391 (10124) :939-948
[8]   SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era [J].
Kang, Jeehoon ;
Han, Jung-Kyu ;
Kang, Do-Yoon ;
Zheng, Chengbin ;
Yang, Han-Mo ;
Park, Kyung-Woo ;
Kang, Hyun-Jae ;
Koo, Bon-Kwon ;
Kim, Hyo-Soo .
KOREAN CIRCULATION JOURNAL, 2020, 50 (01) :22-34
[9]   Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease [J].
Kogame, Norihiro ;
Takahashi, Kuniaki ;
Tomaniak, Mariusz ;
Chichareon, Ply ;
Modolo, Rodrigo ;
Chang, Chun Chin ;
Komiyama, Hidenori ;
Katagiri, Yuki ;
Asano, Taku ;
Stables, Rod ;
Fath-Ordoubadi, Farzin ;
Walsh, Simon ;
Sabate, Manel ;
Davies, Justin E. ;
Piek, Jan. J. ;
van Geuns, Robert-Jan ;
Reiber, Johan H. C. ;
Banning, Adrian P. ;
Escaned, Javier ;
Farooq, Vasim ;
Serruys, Patrick W. ;
Onuma, Yoshinobu .
JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (20) :2064-2075
[10]   Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial [J].
Mohr, Friedrich W. ;
Morice, Marie-Claude ;
Kappetein, A. Pieter ;
Feldman, Ted E. ;
Stahle, Elisabeth ;
Colombo, Antonio ;
Mack, Michael J. ;
Holmes, David R., Jr. ;
Morel, Marie-angele ;
Van Dyck, Nic ;
Houle, Vicki M. ;
Dawkins, Keith D. ;
Serruys, Patrick W. .
LANCET, 2013, 381 (9867) :629-638